Latest Asx Company Filings News

Mantle Minerals reports encouraging drilling results confirming Hemi-style gold mineralisation at Mount Berghaus and Roberts Hill, setting the stage for expanded exploration in 2025.

Oakajee Corporation’s recent auger drilling at the Paynes Find Gold Project yielded disappointing results, with low gold and copper assays suggesting the alluvial cover remains a significant barrier to effective sampling.

Hawthorn Resources has completed a pivotal Pre-Feasibility Study for its Mt Bevan Magnetite project and strategically converted its equity stake into a royalty, positioning the company for future value capture amid evolving market dynamics.

High Peak Royalties has fully repaid its US$750,000 financing facility with Macquarie Bank, removing all associated securities and guarantees. The company signals confidence in its near-term liquidity and operational funding.

Inca Minerals Limited reported steady progress in its December 2024 quarterly activities, focusing on refining exploration targets and securing funding while navigating regulatory and operational challenges.

Tempest Minerals reports maiden drilling success at its Remorse target, revealing significant high-grade magnetite and base metal anomalies with an initial exploration target of up to 110 million tonnes at 30-32% iron.

Recharge Metals has completed the acquisition of the Carter Uranium Project in Montana, USA, adding significant high-grade uranium resources to its portfolio and appointing a seasoned uranium expert to its board.

EVE Health Group has completed the sale of its Robyndale tea tree property and relaunched its postbiotic concentrate range, signaling a strategic shift towards innovation and growth in the Australian market.

Green Critical Minerals has made significant strides in commercialising its Very High-Density (VHD) Graphite technology, achieving exceptional pilot plant results and positioning itself at the forefront of clean energy and electronics markets.

Mako Gold Limited reported a challenging quarter with significant cash outflows and has drawn $500,000 from a $1.5 million loan facility linked to Aurum Resources’ takeover offer. The company’s available funding now covers less than one quarter of its operational needs.

Codeifai Limited has terminated its exclusive licence with MIT and launched a strategic review of its material science division, signaling a decisive pivot towards digital and AI-driven brand solutions.

Avecho Biotechnology progresses its Phase III clinical trial for a TPM®-enhanced CBD insomnia capsule, expands patient recruitment, and completes a major manufacturing campaign for its U.S. partner Ashland.